Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATP5E | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | COQ10A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ATP2B3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CEP78 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TSPO | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | FXN | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TM9SF1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | TMTC4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TCP10L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PRPF19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |